Reboxetine was administered to mice using osmotic pumps. This treatment reduces neuroinflammation and neurodegeneration in an Alzheimer´s disease model.
The reviewer received a reward from Abcam’s Loyalty Program in thanks for submitting this Abreview and for helping the scientific community make better-informed decisions.
Abcam user community
Submitted Sep 19 2019